Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00634816 · ClinicalTrials.gov registry record

Bone Mineral Density in Adult Survivors of Solid Pediatric Cancers

A clinical trial, sponsored by State University of New York - Upstate Medical University.

Completed
Registry status
38
Enrollment target

NCT00634816 is a clinical trial that has completed, run by State University of New York - Upstate Medical University. The registered enrollment target is 38 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00634816 has completed, sponsored by State University of New York - Upstate Medical University.

COMPLETED
Registry status
38 participants
Enrollment target

Study Summary

Specific subgroups of children who survive treatment for childhood malignancies have been shown to develop relative osteopenia following chemotherapy and are felt to be at risk for developing osteoporosis later in life due to their inability to reach peak bone mass during childhood.

Interventions

  • RADIATION DXA Scan

Trial Details

FieldValue
Enrollment Target 38 participants
Start Date 2003-04
Est. Completion 2006-04

What the Registry Record Tells You About NCT00634816

The ClinicalTrials.gov registry entry for NCT00634816 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 38 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is State University of New York - Upstate Medical University, which has 113 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which DXA Scan is the first listed.

NCT00634816 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00634816 about?

NCT00634816 is a clinical study titled "Bone Mineral Density in Adult Survivors of Solid Pediatric Cancers". Specific subgroups of children who survive treatment for childhood malignancies have been shown to develop relative osteopenia following chemotherapy and are felt to be at risk for developing osteoporosis later in life due to their inability to reach peak bone mass during childhood.

What is the current status of trial NCT00634816?

This trial is currently completed. The enrollment target is 38 participants. The study started on 2003-04. Estimated completion is 2006-04.

What interventions are being tested in trial NCT00634816?

The interventions under investigation include: DXA Scan (RADIATION).

Who is sponsoring clinical trial NCT00634816?

This trial is sponsored by State University of New York - Upstate Medical University, which has 113 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.